# A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma

> **NCT07015749** · PHASE1 · RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 12 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Placebo
- **DRUG:** IBI3002

## Key facts

- **NCT ID:** NCT07015749
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2026-05-20
- **Final completion:** 2026-05-20
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07015749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07015749, "A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Asthma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07015749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*